RNA-binding protein IGF2BP2/IMP2 is required for laminin-β2 mRNA translation and is modulated by glucose concentration
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Laminin-β2 (LAMB2) is a critical component of the glomerular basement membrane as content of LAMB2 in part determines glomerular barrier permeability. Previously, we reported that high concentrations of glucose reduce expression of this laminin subunit at the translational level. The present studies were undertaken to further define systems that control Lamb2 translation and the effect of high glucose on those systems. Complementary studies were performed using in vitro differentiation of cultured podocytes and mesangial cells exposed to normal and elevated concentrations of glucose, and tissues from control and diabetic rats. Together, these studies provide evidence for regulation of Lamb2 translation by IMP2, an RNA binding protein that targets Lamb2 mRNA to the actin cytoskeleton. Expression of Imp2 itself is regulated by the transcription factor HMGA2, which in turn is regulated by the microRNA let-7b. Elevated concentrations of glucose increase let-7b, which reduces HMGA2 expression, in turn reducing IMP2 and LAMB2. Correlative changes in kidney tissues from control and streptozotocin-induced diabetic rats suggest these control mechanisms are operative in vivo and may contribute to proteinuria in diabetic nephropathy. To our knowledge, this is the first time that translation of Lamb2 mRNA has been linked to the actin cytoskeleton, as well as to specific RNA-binding proteins. These translational control points may provide new targets for therapy in proteinuric disorders such as diabetic nephropathy where LAMB2 levels are reduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“Correlations between in vitro studies and findings in diabetic rats and that miRs are now recognized as potential therapeutic targets whose selective modulation may alter the course of disease (18, 20, 42) support further studies to test the role of let-7b in DN.”
Result
Research works printed but not linked: 43
- 10.1038/sj.ki.5001706 · doi:10.1038/sj.ki.5001706
- Abrass CK, 1997, Am J Pathol, 151, 1131
- 10.1038/ki.1995.3 · DOI
- 10.1038/ki.1994.313 · DOI
- 10.1186/1465-9921-6-110 · DOI
- Ayo SH, 1990, Am J Pathol, 136, 1339
- 10.1152/ajprenal.1991.260.2.F185 · DOI · Paper page
- 10.1152/ajpcell.00623.2005 · doi:10.1152/ajpcell.00623.2005
- 10.1093/nar/gkm995 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-0264 · DOI · Paper page
- 10.1016/j.febslet.2004.05.075 · DOI · Paper page
- 10.1128/MCB.05263-11 · DOI
- 10.1681/ASN.2010060632 · DOI
- 10.1677/JME-09-0016 · DOI · Paper page
- 10.1158/1541-7786.MCR-06-0331 · DOI · Paper page
- 10.1007/s00441-009-0838-2 · DOI · Paper page
- 10.1046/j.1432-1327.2001.02292.x · doi:10.1046/j.1432-1327.2001.02292.x
- 10.1186/bcr1011 · DOI
- 10.1038/mt.2009.313 · DOI
- 10.1093/nar/30.11.2270 · DOI
- 10.1172/JCI28414 · DOI · Paper page
- 10.1074/jbc.M111284200 · DOI
- 10.1038/nrm2818 · DOI · Paper page
- 10.1038/ki.1983.40 · DOI · Paper page
- 10.1101/gad.1540407 · DOI · Paper page
- 10.1002/humu.21304 · doi:10.1002/humu.21304
- 10.4161/org.7.2.15275 · DOI
- 10.1242/dev.02270 · DOI
- Nielsen FC, 2002, J Cell Sci, 115, 2087, 10.1242/jcs.00103 · DOI
- 10.1038/374258a0 · DOI · Paper page
- 10.1038/ng0895-400 · DOI · Paper page
- 10.1016/S0960-9822(03)00044-7 · DOI · Paper page
- 10.1007/s00018-009-0012-8 · DOI
- 10.2337/diab.43.3.478 · DOI · Paper page
- Saleem MA, 2002, J Am Soc Nephrol, 13, 630, 10.1681/ASN.V133630 · DOI · Paper page
- 10.1016/j.trsl.2011.05.004 · DOI · Paper page
- Schaeffer V, 2009, Am J Physiol Renal Physiol, 297, F314
- 10.1007/s00109-007-0182-5 · DOI
- 10.1161/01.RES.0000138953.21377.80 · DOI · Paper page
- 10.1016/j.semcancer.2008.01.004 · DOI · Paper page
- 10.1073/pnas.1108269108 · DOI
- 10.1006/dbio.1998.8962 · DOI
- 10.1093/hmg/ddh284 · DOI · Paper page
Cited by
Bell, J. L., Wächter, K., Mühleck, B., Pazaitis, N., Köhn, M., Lederer, M., & Hüttelmaier, S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1186-z · Cited by 783
The Diverse Functions of IMP2/IGF2BP2 in Metabolism
Dai, N. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.05.007 · Cited by 114
Bechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
Suo, M., Rommelfanger, M. K., Chen, Y., Amro, E. M., Han, B., Chen, Z., Szafranski, K., Chakkarappan, S. R., Boehm, B. O., MacLean, A. L., et al. (2022) · Blood · doi:10.1182/blood.2021012197 · Cited by 57
Dluzen, D. F., Noren Hooten, N., & Evans, M. K. (2017) · WIREs RNA · doi:10.1002/wrna.1385 · Cited by 31
“Laminin Beta 2 (LAMB2) is part of a family of extracellular glycoproteins and LAMB2 is necessary for normal function of the kidney.(140) The pseudogene hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 4 (HSD3BP4) is transcribed from the 3β-HSD gene cluster(141) and may have a functional role in the activity o…”
Metadata
- Authors
- Schaeffer, V., Hansen, K. M., Morris, D. R., LeBoeuf, R. C., & Abrass, C. K.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2012-07-01
- Volume
- 303
- Issue
- 1
- Pages
- F75-F82
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2109813472
- Cited by
- 50
- References
- 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.